$6.16 -0.01 (-0.16%)
11/20/2009 4:00 PM

Allos Therapeutics, Inc. (ALTH)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Current Price $6.16 Mkt Cap $640.28M
Open $6.12 P/E Ratio 0.00
Prev. Close $6.16 Div. (Yield) N/A (N/A)
Daily Range $6.01 - $6.19 Volume 1,772,451
52-Wk Range $4.68 - $9.30 Avg. Daily Vol. 2,146,000

ALTH News and Commentary

Caps

How do you think ALTH will perform vs the S&P 500?

Add Stock to Watchlist

All Members

233 Outperform
12 Underperform
 

All-Star Members

70 Outperform
4 Underperform
 

Wall Street

13 Outperform
0 Underperform
 

Top ALTH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

codergrrl (24.13)
Submitted January 07, 2008

Allos Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule therapeutics for the treatment of cancer.

0 Comments | Reply | Report this Post

Ruthie203 (23.17)
Submitted February 15, 2008

Wow, I just can't see it. With constant new management, directors, increased stock options, no viable product, living off investor money with promises that FDA might approve 2 bios, seems too risky for me. I might go it if not for the exit of 2… More

0 Comments | Reply | Report this Post
ALTH VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about ALTH.

Recs

0
Member Avatar randomvariable (99.22) Submitted: 10/22/2009 12:34:27 PM : Outperform Start Price: $6.51 ALTH Score: -6.41

Recent FDA action, solid cash position, hopefully this will become profitable.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar spundun (86.33) Submitted: 10/6/2009 8:42:47 PM : Outperform Start Price: $7.18 ALTH Score: -18.16

portefeuille, all stars.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar pprimo (< 20) Submitted: 10/3/2009 10:24:30 PM : Outperform Start Price: $7.14 ALTH Score: -20.07

Because its got cancer treatments recently approved by the FDA that will hit the market in October. This will go from a development/research company to a revenue producing company. the potential for a partnership with a large drug company is high.

Report this Post 0 Comments | Reply | Permalink
View All 28 Pitches »

Leaderboard

Find the members with the highest scoring picks in ALTH.

Score Leader

AirForceFool

AirForceFool (99.94) Score: +96.00

These guys did so well for me, I finally bought some shares (only 100)... made a few bucks on them and closed out about 20% up. They certainly are volatile.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
Gcefaloni < 20 9/18/2006 Outperform 3M $3.65 +68.77% -11.86% +80.62
mtsafe 98.86 10/25/2006 3/2/2008 Outperform 5Y $3.84 +60.42% -15.70% +76.12 1 Comment
Gharabally 85.77 10/26/2006 Outperform 3Y $3.87 +59.17% -16.26% +75.43
Evita100 < 20 10/2/2006 Outperform 1Y $3.80 +62.11% -13.01% +75.11
Rexkay < 20 10/9/2006 Outperform 3M $3.99 +54.39% -13.87% +68.26 1 Comment
HDbaloo 80.00 10/10/2006 Outperform NS $4.01 +53.62% -14.03% +67.65
da723955 < 20 7/17/2007 Outperform 1Y $4.50 +36.89% -25.61% +62.50
Gabers11 22.48 6/22/2007 Outperform 3Y $4.45 +38.43% -23.43% +61.86
hennyhughes < 20 10/20/2006 Outperform 3W $4.31 +42.92% -15.16% +58.09
Maraja 77.48 8/8/2007 Outperform 5Y $4.61 +33.62% -22.91% +56.54
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackLeerinkSwan 83.04 7/14/2009 Outperform NS $7.56 -18.52% +21.66% -40.17
TrackJimCramer 36.31 2/27/2009 Outperform 3W $5.64 +9.22% +50.63% -41.41
TrackWachovia < 20 12/4/2008 Outperform NS $6.01 +2.50% +30.46% -27.96
TrackCitigroup < 20 6/26/2008 Outperform NS $6.49 -5.08% -13.52% +8.44
TrackMichaelBrus 90.02 2/14/2008 Outperform 1Y $6.75 -8.74% -15.63% +6.89
TrackBofASec 91.37 12/4/2007 Outperform NS $7.26 -15.15% -21.83% +6.68
TrackCollinsStew 68.85 11/8/2007 Outperform NS $5.90 +4.41% -22.31% +26.72
TrackSoros 24.12 9/30/2007 Outperform NS $4.75 +29.68% -24.86% +54.54 1 Comment
TrackRBCCapMkts 82.07 6/20/2007 Outperform NS $5.54 +11.19% -24.66% +35.85
TrackJimCramer 36.31 2/13/2007 Underperform 3W $7.78 -27.51% -48.89% -21.39 2/28/2009 @ $5.64
TrackRodmanRen < 20 12/8/2006 Outperform NS $7.13 -13.59% -17.68% +4.09
TrackJMP < 20 12/7/2006 Outperform NS $7.15 -13.85% -18.30% +4.45
TrackUnterberg < 20 12/5/2006 Outperform NS $6.96 -8.19% -6.74% -1.45 6/24/2008 @ $6.39
TrackMDB < 20 10/11/2006 Outperform NS $3.92 +57.14% -13.86% +71.00
TrackNeedham < 20 9/5/2006 Outperform NS $4.16 +48.08% -11.29% +59.37

Featured Broker Partners